The Health Service Executive has now commissioned a full Health Technology Assessment of the FreeStyle Libre flash glucose monitoring system to be conducted by the National Centre for Pharmacoeconomics (NCPE) in collaboration with the Medicines Management Programme. This process has commenced as evidenced by the NCPE call for patient group submissions in recent weeks.Consultant Endocrinologists/Diabetes Nurse Specialists may apply to the HSE, on behalf of specific patients, for reimbursement support of FreeStyle Libre flash glucose monitoring sensors. The application process is undertaken by means of a dedicated online portal, which has been operational since 3rd April 2018. In line with the recommendations outlined by the Health Technology Assessment Group, access to this product was made available to children and young adults, aged 4 - 21 years. However, the application process does cater for the Consultant to make an application in very exceptional circumstances for a type 1 diabetic patient outside of this group.